Australia markets closed

Curative Biotechnology, Inc. (CUBT)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0180+0.0001 (+0.56%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0179
Open0.0179
Bid0.0150 x 0
Ask0.0180 x 0
Day's range0.0179 - 0.0179
52-week range0.0019 - 0.0400
Volume4,124
Avg. volume172,489
Market cap16.259M
Beta (5Y monthly)223.07
PE ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings date05 Aug 2024 - 09 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors

    Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced the nomination to its Board of Directors of Dr. Theresa Heah. Dr. Heah is expected to join its Board of Directors immediately as an independent director. In addition to other Board duties Dr. Heah will serve on the newly created Cl

  • GlobeNewswire

    Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors

    Appointment of Independent Director to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced its nomination to its Board of Directors of Dr. Jeffrey Liebmann. Dr. Liebmann is expected to join its Board of Directors as an indepe